GREENWOOD CAPITAL ASSOCIATES LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1161822
GREENWOOD, SC
Position in VRTX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$5,972,681
+$569,101 QoQ
Shares Held
12,024
-0.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.89%
of 13F equity value
Holder Rank
#443
of 1,735 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREENWOOD CAPITAL ASSOCIATES LLC holds $17,673,711 across 9 Biotechnology names. VRTX ranks #2 (33.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,873 | $8,650,370 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
12,024 | $5,972,681 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
7,752 | $606,749 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,495 | $555,646 | |
| 5 | EXEL |
Exelixis, Inc.
|
8,152 | $443,550 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
773 | $415,062 | |
| 7 | INCY |
Incyte Corp
|
3,319 | $376,241 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
6,121 | $333,839 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,972,681 | 12,024 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $5,403,580 | 12,101 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,586,301 | 12,322 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $5,017,691 | 12,812 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $4,584,669 | 10,298 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $5,765,964 | 11,893 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $7,435,855 | 18,465 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $9,545,301 | 20,524 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $9,933,582 | 21,193 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $8,416,631 | 20,135 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $10,312,627 | 25,345 | Shares | Sole | 2024-03-05 | |
| 2023-09-30 | $7,917,692 | 22,769 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $9,923,158 | 28,198 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $8,983,590 | 28,513 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,127,134 | 28,143 | Shares | Other | 2023-01-26 | |
| 2022-09-30 | $8,807,516 | 30,419 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $8,789,875 | 31,193 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $66,547 | 255 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $12,147,393 | 55,316 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $10,075,851 | 55,548 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $9,946,206 | 49,329 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,754,871 | 22,127 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,686,385 | 19,829 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||